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171 
We examined hepatic expressions of hepatocyte growth factor (託GF)andHGF receptor(c-
met) in liver diseases. Liver tissues from 62 patients with 1iver diseases were examined for 
their expression of HGF and c-met protein by means of an immunohistochemica1 technique 
using po1yclona1 HGF and c-met antibody， respective1y. Immunoreactivity for HGF was 
noted in hepatocytes and bi1iary epithe1ia1 cels. Intense immunoreactivity was observed in 
acute hepatitis (AH) ， chronic hepatitis (CH) and 1iver cirrhosis (LC) ， a1though no immunoreac-
tivity was seen in hepatocellu1ar carcinoma (HCC). c-met protein was expressed in hepa印刷
cytes and biliary epithe1ia1 cels. The expression of c-met protein was higher in patients 
with HCC and AH than in those with CH. The corre1ation of immunoreactivity between 
HGF and c-met was observed on1y in patients with LC. The resu1ts of the present study 
indicate that HGF and c-met proteins are high1y expressed in liver diseases. However， the 
expression of the two proteins is not identica1 except in LC. Therefore， HGF may p1ay an 
important ro1e in human 1iver diseases， most1y in a manner independent of c-met expres-
sion. (Accepted on ]anuary 8， 1997) 
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平均:tSD.
a:1gM-HA抗体， HBs抗原， HCV抗体陰性
b:p<O.Ol vs CH or AH. c:p<O.Ol vs CH. d:p<O.Ol vs HCC. e:p<0.05 vs HCC. 
































































AH:急性肝炎， CH:慢性肝炎， LC:肝硬変， HCC:肝細胞癌
(AH， CH， LC， HCC):陽性細胞を，肝細胞，胆管上皮細胞，肝癌細胞に認める.
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急性肝炎 慢性肝炎 肝硬変 肝細胞癌 全疾患
r p r p r p r p r p 
sHGF vs Bilirubin 0.76 0.1319 -0.31 0.3580 0.08 0.8860 0.62 0.9661 0.59 0.0009 
sHGF vs Albumin -0.46 0.4384 -0.18 0.6061 -0.41 0.4142 0.02 0.9630 -0.31 0.1096 
sHGF vs AST -0.43 0.4653 -0.17 0.6245 0.84 0.0355 0.43 0.3969 -0.06 O. 7792 
sHGF vs ALT -0.29 0.6361 一0.21 0.5328 0.51 0.3055 0.670.2017 く0.01 0.9924 
sHGF vs ALP 0.30 0.6994 0.19 0.5749 -0.05 0.9195 0.31 0.5524 0.24 0.2280 
sHGF vs r-GTP 0.72 0.2850 -0.35 0.2915 -0.37 0.4622 0.32 0.6043 0.43 0.0286 
sHGF vs LDH -0.28 0.7169 0.25 0.4497 -0.08 0.8810 0.40 0.4282 0.04 0.8258 
sHGF vs r-globulin 0.38 0.6179 -0.40 0.2844 0.40 0.4316 -0.84 0.0731 く0.01 0.9999 
sHGF vs AFP -0.19 0.8118 0.11 0.7559 一0.13 0.8051 -0.41 0.4254 一0.05 0.8224 
sHGF vs Prothrombin time -0.49 0.5056 -0.29 0.4238 0.20 0.1143 -0.15 0.7715 -0.18 0.3830 
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